Endometrial hyperplasia and adenocarcinoma during tibolone (Livial®) therapy
- 1 February 1994
- journal article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 101 (2) , 158-161
- https://doi.org/10.1111/j.1471-0528.1994.tb13085.x
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Org OD 14 and the endometriumMaturitas, 1991
- Cancer and Other Risk Factors with Estrogen ReplacementActa Obstetricia et Gynecologica Scandinavica, 1987
- Use of Org OD 14 for the treatment of climacteric complaintsMaturitas, 1987
- Pharmacological studies with (7α,17α)-17-hydroxy-7-methyl-19-norpregn-5(10)-en-20-yn-3-one (Org OD 14)Maturitas, 1987
- Multicentre study of effects of Org OD 14 on endometrium, vaginal cytology and cervical mucus in post-menopausal and oophorectomized womenMaturitas, 1984
- Prospective double-blind trial of synthetic steroid (Org OD 14) for preventing postmenopausal osteoporosis.BMJ, 1980
- The Prevention and Treatment of Endometrial Pathology in Postmenopausal Women receiving Exogenous EstrogensPublished by Springer Nature ,1980
- Endometrial Histology and Biochemistry in Climacteric Women during Oestrogen and Oestrogen/Progestogen TherapyJournal of the Royal Society of Medicine, 1979